News

Germany’s Merck Nears Roughly $3.5 Billion Deal for SpringWorks
Germany’s Merck KGaA is finally nearing a roughly $3.5 billion deal for SpringWorks Therapeutics, a U.S. biopharmaceutical ...
Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
Trump Tariffs News: Stocks Gain; China Says Not in Trade Talks With U.S.
Trump’s trade war continues to affect global markets as investors monitor the latest developments with China. Follow along for live updates on the Dow, S&P 500 and Nasdaq.